Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/9830
Title: | Protective effect of bergapten in acetic acid-induced colitis in rats |
Authors: | Adakudugu, Emmanuel A. Ameyaw, Elvis O. Obese, Ernest Biney, Robert P. Henneh, Isaac T. Aidoo, Douglas B. Oge, Elizabeth N. Attah, Isaac Y. Obiri, David D. |
Keywords: | Pharmaceutical science Immunology Pathology Physiology Bergapten Ulcerative colitis Furanocoumarin Mast cells Immune modulators Biological sciences Gastrointestinal system Pharmacology Evidence-based medicine |
Issue Date: | 2020 |
Publisher: | Heliyon |
Abstract: | Bergapten (5-methoxysporalen) is a furanocoumarin extracted from several species of citrus and bergamot oil. Bergamot essential oil is used traditionally in the management of inflammatory conditions. Previous studies on bergapten have explored mainly its in vitro anti-inflammatory activities which include suppression of the expression and release of pro-inflammatory cytokines such as TNF-α and interleukins as well as prostaglandins. Bergapten enhances the clearance of neutrophils and macrophages from the site of inflammation and reduces oxidative stress by inhibition of reactive oxygen species (ROS). Bergapten was assessed for its anti-inflammatory properties in acetic acid-induced colitis. Animals were obtained and randomly placed in six (6) groups (n ¼ 5) after acclimatization. Colitis was induced by rectal administration using 4% v/v acetic acid in Sprague Dawley rats after pre-treatment for 5 days. Bergapten was administered at doses of 3, 10, and 30 mg kg1 p.o. while the control group received saline 5 mL kg1 p.o. and the standard drug employed was sulphasalazine at a dose of 500 mg kg1. Assessments made for colon-weight-to-length ratio, colonic injury, and mucosal mast cell degranulation. There were reduced colon-weight-to-length ratios in animals treated with bergapten which was significant (p < 0.5) for doses 10 and 30 mg kg1 compared to the disease control group Both macroscopic and microscopic damage were reduced as well, with a lesser percentage of degranulated mast cells. Macroscopic damage was reduced for bergapten at doses 10 and 30 mg kg1 significantly at p < 0.5 and p < 0.001, respectively. Similarly, microscopic damage was reduced at p < 0.01 and p < 0.001 respectively for bergapten 10 and 30 mg kg1. The reduction of degranulation by bergapten was significant at p < 0.001. There was generally reduced damage at inflammatory sites as well as decreased infiltration of inflammatory cells. Overall, bergapten reduces inflammation in acetic acid-induced colitis. |
URI: | http://hdl.handle.net/123456789/9830 |
Appears in Collections: | School of Medical Sciences |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
rotective effect of bergapten in acetic acid-induced colitis in rats.pdf | MAIN ARTICLE | 1.08 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.